Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.4. Antileprosy medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.2. Antileprosy med. |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| PAHO Strategic Fund Medicine List | 2.4. Antiberculosis med. 2nd line | No observations |
| Peru | 6.2.3 Anti-Leprosy | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 02. Antibióticos | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
| El Salvador - 2019 | ANTIMICOBACTERIANOS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 7.03. Antileprosy Medicines | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines | No observations |
| Haiti. National List of Essential Medicines | 06.02.03 Antileprosy | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.4. Antileprosy medicines | No observations |
| PAHO Strategic Fund Medicine List | 2.2. Antileprosy med. |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| PAHO Strategic Fund Medicine List | 2.4. Antiberculosis med. 2nd line | No observations |
| Peru | 6.2.3 Anti-Leprosy | No observations |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 07.02 ANTILEPROTIC DRUGS | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
| El Salvador - 2019 | ANTIMICOBACTERIANOS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 7.03. Antileprosy Medicines | No observations |
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines | No observations |
| Haiti. National List of Essential Medicines | 06.02.03 Antileprosy | No observations |
| List | Section | Observation |
|---|---|---|
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.02. ANTIBACTERIANOS | No observations |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.02. ANTIBACTERIANOS | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 08.16.92 Miscellaneous Antimycobacterials | No observations |
| List | Section | Observation |
|---|---|---|
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 8:38 Anti-leprotic agents | No observations |
| Suriname. NGK-C-011 | 6.05 Anti-Leprosy drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Suriname. NGK-C-011 | 6.05 Anti-Leprosy drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: x 100 tabletas |